// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "DDA MAY USE CL RIGHTS PATO OF BRENDA MINOR TAB disease HCD biological replicate OPTIONAL URL MERCHANTABILITY CID CN spiked compound INITIATIVE source name CPTAC SP XL IMPLIED MS:1001251 TA DTT file your PURPOSE technical replicate individual HF MHC SH HEREIN CELL PRIDE label TO FDR instrument IDF sex replicate INFORMATION URI SHOULD FOR ... CLO HTML DOID CS UBERON MIAME RFC MOD REQUIRES characteristics III AC OR PARTICULAR mass NCE SDRF BUT cell type TMT SRM PROTEOMICS reduction reagent source name_ and _assay name PRIDE:0000659 SN PATCH organism NCBI CF data file depletion NT VK HANCESTRO II MS ISA MT IS HUPO MAJOR MANDATORY JA PMID INFRINGE EW proteomics data acquisition method biosample accession number developmental stage cleavage agent details CV EBI alkylation reagent WILL RAW fractionation method MC THE LIMITED PTM COLUMN organism part EXPRESS ROW SILAC REQUIRED CT fraction identifier BTO AS age SHALL SWATH TIP disease stage INCLUDING ENVO MONDO PP exclamation VCF EM ancestry category LC PRM WARRANTY ALL XML README PEPTIDESEQ ID WARRANTIES IAA RECOMMENDED RECOMMEND PSI DJ MAGE EFO dissociation method QY DISCLAIMS PS FITNESS THAT collision energy ANY IMPORTANT PO sample BE NOTE MUST LI COULD ZFA PMCID DIA NOT pooled sample BMC STANDARDS"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "DDA MAY USE CL RIGHTS PATO OF BRENDA MINOR TAB disease HCD biological replicate OPTIONAL URL MERCHANTABILITY CID CN spiked compound INITIATIVE CPTAC SP XL IMPLIED MS:1001251 TA DTT PURPOSE technical replicate individual HF MHC SH HEREIN CELL PRIDE label TO FDR instrument IDF sex INFORMATION URI SHOULD FOR ... CLO HTML DOID CS UBERON MIAME RFC MOD REQUIRES III AC OR PARTICULAR mass NCE SDRF BUT cell type TMT SRM PROTEOMICS reduction reagent PRIDE:0000659 SN PATCH organism NCBI CF data file depletion NT VK HANCESTRO II MS ISA MT IS HUPO MAJOR MANDATORY JA PMID INFRINGE EW proteomics data acquisition method biosample accession number cleavage agent details CV EBI alkylation reagent WILL RAW fractionation method MC THE LIMITED PTM COLUMN organism part EXPRESS ROW SILAC REQUIRED CT fraction identifier BTO AS age SHALL SWATH disease stage INCLUDING ENVO MONDO PP VCF EM ancestry category LC PRM WARRANTY ALL README PEPTIDESEQ WARRANTIES IAA RECOMMENDED RECOMMEND PSI DJ MAGE EFO dissociation method QY DISCLAIMS PS FITNESS THAT collision energy ANY PO BE MUST LI COULD ZFA PMCID DIA NOT pooled sample BMC STANDARDS"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "enrichment process MONDO:0004975 MAY UBERON:0002097 CL:0000451 CL UBERON:0001359 PATO compound disease PATO:0001340 CML biological replicate URL CL:0000623 PDX APP PATO:0000384 MONDO:0005138 CL:0000066 source name synthetic peptide CL:0000787 UBERON:0002107 NK CL:0000788 MONDO:0005301 individual MONDO:0005180 CL:0000898 CSF sex CL:0000815 SHOULD MONDO:0008383 CL:0000540 DOID UBERON UBERON:0002113 UBERON:0001088 SDRF cell type CL:0000233 PATO:0000461 NSG UBERON:0001977 CL:0000624 organism NCBI depletion HANCESTRO MONDO:0005575 developmental stage UBERON:0002048 CL:0000236 PTM MONDO:0100096 organism part CL:0000182 CL:0000235 age TIP CL:0000084 MONDO:0005148 MONDO exclamation ancestry category ALL CL:0000232 CL:0000576 ID UBERON:0001969 UBERON:0000178 disease model UBERON:0000948 PATO:0000383 COVID UBERON:0000310 EFO UBERON:0001155 MONDO:0004946 CL:0000813 CL:0000057 MONDO:0004989 CL:0000625 IMPORTANT PO lib NOTE MUST MONDO:0005105 UBERON:0000955 xenograft CL:0000913 DSS"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "enrichment process MONDO:0004975 MAY UBERON:0002097 CL:0000451 CL UBERON:0001359 PATO compound disease PATO:0001340 CML biological replicate URL CL:0000623 PDX APP PATO:0000384 MONDO:0005138 CL:0000066 source name synthetic peptide CL:0000787 UBERON:0002107 NK CL:0000788 MONDO:0005301 individual MONDO:0005180 CL:0000898 CSF sex CL:0000815 SHOULD MONDO:0008383 CL:0000540 DOID UBERON UBERON:0002113 UBERON:0001088 SDRF cell type CL:0000233 PATO:0000461 NSG UBERON:0001977 CL:0000624 organism NCBI depletion HANCESTRO MONDO:0005575 developmental stage UBERON:0002048 CL:0000236 PTM MONDO:0100096 organism part CL:0000182 CL:0000235 age CL:0000084 MONDO:0005148 MONDO ancestry category ALL CL:0000232 CL:0000576 ID UBERON:0001969 UBERON:0000178 disease model UBERON:0000948 PATO:0000383 COVID UBERON:0000310 EFO UBERON:0001155 MONDO:0004946 CL:0000813 CL:0000057 MONDO:0004989 CL:0000625 PO MUST MONDO:0005105 UBERON:0000955 xenograft CL:0000913 DSS"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C4870 NCIT:C81327 NCI MONDO:0004979 alcohol consumption weight breast cancer subtype PREFERRED NCIT:C14168 NCIT:C28054 compound NCIT:C28079 disease NCIT:C18206 TNM NCIT:C62723 NCIT:C81328 menopausal status PR ER NCIT:C16358 gestational age MONDO:0002050 individual PD NCIT:C14169 MONDO:0005044 secondary condition treatment NCIT:C15262 CHEBI:28748 NCIT:C27966 NCIT:C28077 sex NCIT:C15329 HANCESTRO:0009 diet CHEBI:27899 III MONDO:0005300 SDRF treatment response height NCIT:C15445 sampling time point organism HANCESTRO:0005 smoking status II HANCESTRO NCIT:C28078 NCIT:C15313 dose GDPR MONDO:0004995 ACE prior treatment pre-existing condition NCIT NCIT:C27971 organism part NCIT:C53556 UO NCIT:C15632 NCIT:C18058 NCIT:C65106 age Dukes stage CHEBI:41774 treatment status BMI disease stage IV NCIT:C14174 NCIT:C14167 NCIT:C18213 MONDO:0005148 NCIT:C68804 MONDO exclamation NCIT:C65108 ancestry category NCIT:C28076 NCIT:C53554 ID body mass index HIPAA NCIT:C71732 EFO NCIT:C53553 medication history tumor grade HANCESTRO:0006 NCIT:C53555 CHEBI:6801 NCIT:C65107 IMPORTANT ethnicity NCIT:C27970 Ann Arbor stage NOTE time post treatment HANCESTRO:0010 TNM staging MONDO:0011122 pregnancy status AJCC"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C4870 NCIT:C81327 NCI MONDO:0004979 alcohol consumption weight breast cancer subtype PREFERRED NCIT:C14168 NCIT:C28054 compound NCIT:C28079 disease NCIT:C18206 TNM NCIT:C62723 NCIT:C81328 menopausal status PR ER NCIT:C16358 gestational age MONDO:0002050 individual PD NCIT:C14169 MONDO:0005044 secondary condition treatment NCIT:C15262 CHEBI:28748 NCIT:C27966 NCIT:C28077 sex NCIT:C15329 HANCESTRO:0009 diet CHEBI:27899 III MONDO:0005300 SDRF treatment response height NCIT:C15445 sampling time point organism HANCESTRO:0005 smoking status II HANCESTRO NCIT:C28078 NCIT:C15313 dose GDPR MONDO:0004995 ACE prior treatment pre-existing condition NCIT NCIT:C27971 organism part NCIT:C53556 UO NCIT:C15632 NCIT:C18058 NCIT:C65106 age Dukes stage CHEBI:41774 treatment status BMI disease stage IV NCIT:C14174 NCIT:C14167 NCIT:C18213 MONDO:0005148 NCIT:C68804 MONDO NCIT:C65108 ancestry category NCIT:C28076 NCIT:C53554 ID body mass index HIPAA NCIT:C71732 EFO NCIT:C53553 medication history tumor grade HANCESTRO:0006 NCIT:C53555 CHEBI:6801 NCIT:C65107 ethnicity NCIT:C27970 Ann Arbor stage time post treatment HANCESTRO:0010 TNM staging MONDO:0011122 pregnancy status AJCC"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "MS:1001917 precursor mass tolerance proteomics data acquisition method instrument RECOMMENDED KR DDA MS:1001309 URI SCIEX SHOULD ID RAW MM PSI scan window lower limit cleavage agent details MS:1001303 MS1 scan range ELISA UNIMOD:4 CS MOD SILAC MS2 analyzer type REQUIRED URL FTP AC fraction identifier LTQ scan window upper limit TOF modification parameters IMPORTANT SDRF PRIDE:0000663 UNIMOD:737 TMT TIP SRM MRM MGF file uri sample UNIMOD:35 NOTE MUST XL UNIMOD:1 MS:1001313 proteomexchange accession number ST MSD CF data file NT TS MS:1001251 UNIMOD:21 MS:1001306 TA exclamation PP technical replicate UNIMOD MS HF fragment mass tolerance DIA PRM MT fraction label PRIDE RPPA"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "MS:1001917 precursor mass tolerance proteomics data acquisition method instrument RECOMMENDED KR DDA MS:1001309 URI SCIEX SHOULD ID RAW MM PSI scan window lower limit cleavage agent details MS:1001303 MS1 scan range ELISA UNIMOD:4 CS MOD SILAC MS2 analyzer type REQUIRED URL FTP AC fraction identifier LTQ scan window upper limit TOF modification parameters SDRF PRIDE:0000663 UNIMOD:737 TMT SRM MGF MRM file uri UNIMOD:35 MUST XL UNIMOD:1 MS:1001313 proteomexchange accession number ST MSD CF data file NT TS MS:1001251 UNIMOD:21 MS:1001306 TA PP technical replicate UNIMOD MS HF fragment mass tolerance DIA PRM MT label PRIDE RPPA"
  }
];
